Amarin Corp Plc (AMRN)

[BioChica]

They did not used the "active ingredient" approach, but revised ingredient / moiety analysis(1 to 1 instead of 1 to many regarding AI - AM relation) during the new determination, resulted in NCE.

I thought the Judge wrote/said - The FDA must use the ingredient, rather than moity for determining NCE, as defined in Hatch-Waxman law!

I would like to see the FDA in front of this Judge again, deciding NCE case!